Addressing Biomedical Science’s PhD Problem

Researchers and institutions seek to bridge the gap between emerging life science professionals and available positions.

Written byCatherine Offord
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

© iSTOCK.COM/THEADESIGNPhD degrees aren’t what they used to be. In 1973, more than half of doctoral degree graduates in biological sciences landed a tenure-track position within six years. Three decades later, that fraction had dropped to 15 percent. Demand has not kept pace with supply, says Bruce Alberts, a professor of biochemistry at the University of California, San Francisco (UCSF), and cofounder of the nonprofit organization Rescuing Biomedical Research (RBR). “The real world for [biomedical PhD students] is that maybe a fifth will ever get academic jobs,” he says. And it’s not just academia that’s overpopulated, he adds. “There aren’t even enough jobs currently in the private sector to make it possible for all of them to get research jobs.”

As a result, trainees spend more and more time in postdoctoral positions, and even then, their chances of landing a tenure-track position are in decline. Several years of survey data collected by the American Association for the Advancement of Science (AAAS) show that, although the percentage of postdocs expecting to land a tenure-track faculty position stayed above 50 percent from 2010 to 2012, the percentage who actually do so fell from 37 percent to 21 percent. Unemployment following a postdoc position, meanwhile, rose from 2 percent to 10 percent over the same time period.

Yet despite these sobering statistics, PhD programs continue to grow—in the U.S., the life sciences saw an increase from around 8,000 doctoral recipients in 2004 to more than 12,500 a decade ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile

Published In

January 2017

Driving Out Disease

Scenarios for the genetic manipulation of mosquito vectors

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies